Sign in

CIK 0001711279 · Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
821080209
Phone
(412) 586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
  1. 4 Planned sale President, R&D sold 50,000 shares at an average $197.77 ($9,888,276)
  2. 4 Planned sale President and CEO sold 50,000 shares at an average $197.77 ($9,888,276)
  3. 4 Gift Director gave 5,000 shares (gift)
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 8-K Event Regulation FD disclosure
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Planned sale President, R&D sold 50,000 shares at an average $175.76 ($8,788,062)
  18. 4 Planned sale President and CEO sold 50,000 shares at an average $175.76 ($8,788,062)
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 7 of 26 · 513 filings